1. Home
  2. SIGI vs APGE Comparison

SIGI vs APGE Comparison

Compare SIGI & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Selective Insurance Group Inc.

SIGI

Selective Insurance Group Inc.

N/A

Current Price

$92.78

Market Cap

5.8B

Sector

Finance

ML Signal

N/A

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

N/A

Current Price

$134.28

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIGI
APGE
Founded
1926
2022
Country
United States
United States
Employees
2800
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.7B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
SIGI
APGE
Price
$92.78
$134.28
Analyst Decision
Hold
Strong Buy
Analyst Count
5
13
Target Price
$85.80
$109.67
AVG Volume (30 Days)
506.3K
1.7M
Earning Date
04-22-2026
05-12-2026
Dividend Yield
2.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.41
N/A
Revenue Next Year
$4.81
N/A
P/E Ratio
$11.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$72.78
$34.34
52 Week High
$100.40
$134.40

Technical Indicators

Market Signals
Indicator
SIGI
APGE
Relative Strength Index (RSI) 46.06 80.53
Support Level $92.29 $80.52
Resistance Level $100.40 N/A
Average True Range (ATR) 2.78 0.33
MACD -0.50 -1.74
Stochastic Oscillator 11.80 89.75

Price Performance

Historical Comparison
SIGI
APGE

About SIGI Selective Insurance Group Inc.

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: